These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 34812146)

  • 1. Data mining methodology for response to hypertension symptomology-application to COVID-19-related pharmacovigilance.
    Xu X; Kawakami J; Millagaha Gedara NI; Riviere JE; Meyer E; Wyckoff GJ; Jaberi-Douraki M
    Elife; 2021 Nov; 10():. PubMed ID: 34812146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacovigilance in patients with diabetes: A data-driven analysis identifying specific RAS antagonists with adverse pulmonary safety profiles that have implications for COVID-19 morbidity and mortality.
    Stafford EG; Riviere JE; Xu X; Kawakami J; Wyckoff GJ; Jaberi-Douraki M
    J Am Pharm Assoc (2003); 2020; 60(6):e145-e152. PubMed ID: 32561317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary adverse drug event data in hypertension with implications on COVID-19 morbidity.
    Jaberi-Douraki M; Meyer E; Riviere J; Gedara NIM; Kawakami J; Wyckoff GJ; Xu X
    Sci Rep; 2021 Jun; 11(1):13349. PubMed ID: 34172790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research on Beers Criteria and STOPP/START Criteria based on the FDA FAERS database.
    Shao Q; Xu Y; Li M; Chu X; Liu W
    Eur J Clin Pharmacol; 2021 Aug; 77(8):1147-1156. PubMed ID: 34170370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in spontaneous reports on adverse drug events for common antihypertensive drugs.
    Rydberg DM; Mejyr S; Loikas D; Schenck-Gustafsson K; von Euler M; Malmström RE
    Eur J Clin Pharmacol; 2018 Sep; 74(9):1165-1173. PubMed ID: 29804162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19.
    Reynolds HR; Adhikari S; Pulgarin C; Troxel AB; Iturrate E; Johnson SB; Hausvater A; Newman JD; Berger JS; Bangalore S; Katz SD; Fishman GI; Kunichoff D; Chen Y; Ogedegbe G; Hochman JS
    N Engl J Med; 2020 Jun; 382(25):2441-2448. PubMed ID: 32356628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Making Sense of Pharmacovigilance and Drug Adverse Event Reporting: Comparative Similarity Association Analysis Using AI Machine Learning Algorithms in Dogs and Cats.
    Xu X; Mazloom R; Goligerdian A; Staley J; Amini M; Wyckoff GJ; Riviere J; Jaberi-Douraki M
    Top Companion Anim Med; 2019 Dec; 37():100366. PubMed ID: 31837760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of blood-pressure-lowering treatment in hypertension: 9. Discontinuations for adverse events attributed to different classes of antihypertensive drugs: meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2016 Oct; 34(10):1921-32. PubMed ID: 27454050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute renal failure and cardiac arrhythmias associated with remdesivir use in patients with COVID-19 infections: Analysis using the US FDA adverse event reporting system.
    Orogun L; Chyou TY; Nishtala PS
    Int J Risk Saf Med; 2023; 34(2):87-99. PubMed ID: 37154187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the nervous system and gastrointestinal adverse events associated with solifenacin in older adults using the US FDA adverse event reporting system.
    Nicholls C; Chyou TY; Nishtala PS
    Int J Risk Saf Med; 2023; 34(1):63-73. PubMed ID: 35491805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients.
    Semenzato L; Botton J; Drouin J; Baricault B; Vabre C; Cuenot F; Penso L; Herlemont P; Sbidian E; Weill A; Dray-Spira R; Zureik M
    Hypertension; 2021 Mar; 77(3):833-842. PubMed ID: 33423528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mining multi-item drug adverse effect associations in spontaneous reporting systems.
    Harpaz R; Chase HS; Friedman C
    BMC Bioinformatics; 2010 Oct; 11 Suppl 9(Suppl 9):S7. PubMed ID: 21044365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database.
    Sonawane KB; Cheng N; Hansen RA
    J Manag Care Spec Pharm; 2018 Jul; 24(7):682-690. PubMed ID: 29952714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leveraging MEDLINE indexing for pharmacovigilance - Inherent limitations and mitigation strategies.
    Winnenburg R; Sorbello A; Ripple A; Harpaz R; Tonning J; Szarfman A; Francis H; Bodenreider O
    J Biomed Inform; 2015 Oct; 57():425-35. PubMed ID: 26342964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders.
    Boal AH; Smith DJ; McCallum L; Muir S; Touyz RM; Dominiczak AF; Padmanabhan S
    Hypertension; 2016 Nov; 68(5):1132-1138. PubMed ID: 27733585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14 - effects of different classes of antihypertensive drugs in older and younger patients: overview and meta-analysis.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2018 Aug; 36(8):1637-1647. PubMed ID: 29847487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.